Effect of cyclosporine A on hepatic carbohydrate metabolism and hepatic gene expression in rat

Bibliography

• Vincenti F, Friman S, Scheuermann E, Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007;7(6):1506-14
   PubMed Web of Science ®Google Scholar
• Weir M. Impact of immunosuppressive regimes on posttransplant diabetes mellitus. Transplant Proc 2001;33(5A Suppl):23S-26S
   Google Scholar
• Hariharan S, Johnson CP, Bresnahan BA, Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342(9):605-12
   PubMed Web of Science ®Google Scholar
• Akhlaghi F, Trull AK. Distribution of cyclosporin in organ transplant recipients. Clin Pharmacokinet 2002;41(9):615-37
   PubMed Web of Science ®Google Scholar
• Nielsen JH, Mandruppoulsen T, Nerup J. Direct effects of cyclosporine-A on human pancreatic beta-cells. Diabetes 1986;35(9):1049-52
   PubMed Web of Science ®Google Scholar
• Drachenberg CB, Klassen DK, Wiland A, Islet cell damage associated with tacrolimus and cyclosporine. Morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999;67(7):S209-S
   Google Scholar
• Hjelmesaeth J, Hagen LT, Asberg A, The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transpl 2007;22(6):1743-9
   PubMed Web of Science ®Google Scholar
• Yale JF, Chamelian M, Courchesne S, Vigeant C. Peripheral insulin resistance and decreased insulin-secretion after cyclosporine-A treatment. Transplant P 1988;20(3):985-8
   PubMed Web of Science ®Google Scholar
• Ozbay LA, Smidt K, Mortensen DM, Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells. Br J Pharmacol 2011;162(1):136-46
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Liang KH, Azad H. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7 alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions. J Pharmacol Exp Ther 2000;294(2):778-83
   PubMed Web of Science ®Google Scholar
• Boden G, Chen X, Ruiz J, Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994;93(6):2438-46
   PubMed Web of Science ®Google Scholar
• Wahlstrom HE, Lavellejones M, Endres D, Inhibition of insulin release by cyclosporine and production of peripheral insulin resistance in the dog. Transplantation 1990;49(3):600-4
   PubMed Web of Science ®Google Scholar
• Ikeuchi M, Kida K, Goto Y, In vivo and in vitro effects of cyclosporin A on glucose transport by soleus muscles of mice. Biochem Pharmacol 1992;43(7):1459-63
   PubMed Web of Science ®Google Scholar
• Midtvedt K, Hjelmesaeth J, Hartmann A, Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004;15(12):3233-9
   PubMed Web of Science ®Google Scholar
• Delgado TC, Barosa C, Nunes PM, Resolving the sources of plasma glucose excursions following a glucose tolerance test in the rat, deuterated water, glucose. PLoS One 2012;7(3):e34042
   Google Scholar
• Mazzoni G, Mazzoni P. Reversibility of graft rejection following a short cyclosporin-A administration 5 days after grafting. Microsurgery 1986;7(3):114-16
   PubMedGoogle Scholar
• Tuglular S, Gogas Yavuz D, Cakalagaoglu F, Cyclosporine-A induced nephrotoxicity is associated with decreased renal bone morphogenetic protein-7 expression in rats. Transplant Proc 2004;36(1):131-3
   PubMed Web of Science ®Google Scholar
• Suga M, Gladdy R, Xing Z, Transplant immunosuppression enhances efficiency of adenoviral-mediated gene retransfection: inhibition of interferon-gamma and immunoglobin G. Ann Thorac Surg 2002;73(4):1092-7
   PubMed Web of Science ®Google Scholar
• Brunner LJ, Bennett WM, Koop DR. Cyclosporine suppresses rat hepatic cytochrome P450 in a time-dependent manner. Kidney Int 1998;54(1):216-23
   PubMed Web of Science ®Google Scholar
• Jin ES, Uyeda K, Kawaguchi T, Increased hepatic fructose 2,6-bisphosphate after an oral glucose load does not affect gluconeogenesis. J Biol Chem 2003;278(31):28427-33
   PubMed Web of Science ®Google Scholar
• Jones JG, Solomon MA, Cole SM, An integrated 2H and 13C NMR study of gluconeogenesis and TCA cycle flux in humans. Am J Physiol Endocrinol Metab 2001;281(4):E848-56
   Google Scholar
• Jones JG, Merritt M, Malloy C. Quantifying tracer levels of 2H2O enrichment from microliter amounts of plasma and urine by 2H NMR. Magn Reson Med 2001;45(1):156-8
   PubMed Web of Science ®Google Scholar
• Soares AF, Viega FJ, Carvalho RA, Jones JG. Quantifying hepatic glycogen synthesis by direct and indirect pathways in rats under normal ad libitum feeding conditions. Magn Reson Med 2009;61(1):1-5
   PubMed Web of Science ®Google Scholar
• Soares AF, Carvalho RA, Veiga FJ, Jones JG. Effects of galactose on direct and indirect pathway estimates of hepatic glycogen synthesis. Metab Eng 2010;12(6):552-60
   PubMed Web of Science ®Google Scholar
• Perdigoto R, Rodrigues TB, Furtado AL, Integration of [U-13C]glucose and 2H2O for quantification of hepatic glucose production and gluconeogenesis. NMR Biomed 2003;16(4):189-98
   PubMed Web of Science ®Google Scholar
• Nunes PM, Carvalho E, Jones JG. Elimination of glucose contamination from adipocyte glycogen extracts. Carbohydr Res 2008;343(9):1486-9
   PubMed Web of Science ®Google Scholar
• Kneteman NM, Marchetti P, Tordjman K, Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants. Surgery 1992;111(4):430-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Perfetti R, Greig NH, Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 1997;99(12):2883-9
   PubMed Web of Science ®Google Scholar
• Cruciani-Guglielmacci C, Vincent-Lamon M, Rouch C, Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone. Am J Physiol Endocrinol Metab 2005;288(1):E148-54
   Google Scholar
• Wajngot A, Chandramouli V, Schumann WC, Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 2001;50(1):47-52
   PubMed Web of Science ®Google Scholar
• Moore MC, Cherrington AD, Palmer B, Disposition of a mixed meal by conscious dogs after seven days of treatment with cyclosporine A and prednisone. J Parenter Enteral Nutr 2000;24(4):244-50
   PubMed Web of Science ®Google Scholar
• Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 2003;284(4):E671-8
   PubMed Web of Science ®Google Scholar
• Martin F, Bedoya FJ. Mechanisms of action of cyclosporin A on islet alpha- and beta-cells. Effects on cAMP- and calcium-dependent pathways. Life Sci 1991;49(25):1915-21
   PubMed Web of Science ®Google Scholar
• Serkova N, Klawitter J, Niemann CU. Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat. Transplant Int 2003;16(10):748-55
   PubMed Web of Science ®Google Scholar
• Riegel W, Stephan E, Balle C, Effect of cyclosporin A on carbohydrate metabolism of isolated rat liver cells. Kidney Int Suppl 1989;27:S236-8
   Google Scholar
• Delgado TC, Barosa C, Castro MM, Sources of hepatic glucose production by 2H2O ingestion and Bayesian analysis of 2H glucuronide enrichment. Magn Reson Med 2008;60(3):517-23
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008;7(2):95-6
   PubMed Web of Science ®Google Scholar
• Wu J, Zhu YH, Patel SB. Cyclosporin-induced dyslipoproteinemia is associated with selective activation of SREBP-2. Am J Physiol 1999;277(6 Pt 1):E1087-94
   Google Scholar
• Torras J, Herrero I, Castells A, Effect of ciclosporin on serum lipids and modification with LSL 90202, a lysine salt of eicosapentaenoic acid. Nephron 1995;69(3):318-22
   PubMedGoogle Scholar